Home › Research › Topics › antibody-treatment
antibody-treatment
3 studies tagged antibody-treatment, dated 2023-09-11 to 2025-04-05. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Practical Brain MRI Guidelines for Anti-Aβ Antibody Treatment in Early Symptomatic Alzheimer's Disease 2025-04-05
- Monoclonal anti-amyloid antibody treatment: the epidemiological profile of the target patients in Austria and the status of treatment-eligible patients registered at an outpatient memory clinic 2024-10-23
- Anti-amyloid antibody treatments for Alzheimer's disease 2023-09-11
Studies
3 studies carry this tag.
Date range
2023 to 2025
Top journals
- European journal of neurology 1
- Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine 1
- Wiener klinische Wochenschrift 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
These guidelines facilitate the accurate diagnosis and effective management of ARIA; ensure the safe administration of anti-Aβ drugs; and provide a framework for MRI facilities, includes staffing requirements and the use of MRI management systems.
-
The development of monoclonal anti-amyloid antibodies, a disease-modifying treatment for Alzheimer's disease (AD), has raised the necessity to identify the epidemiological profile of the possible target patients who would benefit from such therapy.
-
Our aim is to review the most recent evidence on novel antibody therapies for Alzheimer's disease directed against amyloid-β.